Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Suz Jack Chan"'
Publikováno v:
The Patient - Patient-Centered Outcomes Research. 14:505-532
Optimal care of rheumatoid arthritis (RA) patients entails regular assessment of disease activity and appropriate adjustment of disease-modifying antirheumatic drugs (DMARDs) until a predefined treatment goal is achieved. This raises questions about
Publikováno v:
Musculoskeletal Care. 17:161-169
Objectives Biologic therapies have increased the control of disease activity in rheumatoid arthritis (RA). Questions remain about tapering biologics when remission is achieved in RA. The patient perspective has to be incorporated in pragmatic applica
Autor:
Nicola Liebergreen, Suz Jack Chan, Carlo A. Marra, Lisa K. Stamp, Gareth J. Treharne, Henry C. Ndukwe
Publikováno v:
The patient. 13(2)
Biologic therapies are cost effective for active rheumatoid arthritis but have adverse effects and are costly. Tapering of biologics is emerging as an important consideration when sustained remission is achieved. Recent trials have highlighted the cl
Autor:
SUZ JACK CHAN1,2, CHENG LING TAN1 tanchengling@usm.my
Publikováno v:
International Journal of Economics & Management. Dec2016, Vol. 10 Issue 2, p321-342. 22p.